Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of SOX21 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 94% | 796.07 | 2471 / 2642 | 99% | 55.83 | 696 / 705 |
| esophagus | 38% | 450.46 | 543 / 1445 | 49% | 15.24 | 90 / 183 |
| stomach | 64% | 737.38 | 230 / 359 | 17% | 3.70 | 48 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 26.49 | 35 / 45 |
| skin | 72% | 1343.37 | 1296 / 1809 | 2% | 0.55 | 11 / 472 |
| lung | 2% | 4.65 | 11 / 578 | 46% | 16.10 | 530 / 1155 |
| uterus | 1% | 4.44 | 2 / 170 | 46% | 12.50 | 212 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 43% | 5.69 | 77 / 178 |
| bladder | 0% | 0 | 0 / 21 | 22% | 5.32 | 113 / 504 |
| prostate | 7% | 17.33 | 18 / 245 | 6% | 0.70 | 28 / 502 |
| intestine | 0% | 0.74 | 1 / 966 | 10% | 2.40 | 51 / 527 |
| ovary | 0% | 0 | 0 / 180 | 4% | 1.04 | 16 / 430 |
| liver | 0% | 0 | 0 / 226 | 2% | 0.31 | 8 / 406 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0.09 | 3 / 605 |
| breast | 0% | 0 | 0 / 459 | 0% | 0.05 | 5 / 1118 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.03 | 1 / 230 |
| adipose | 0% | 4.57 | 5 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0.02 | 2 / 901 |
| muscle | 0% | 0.24 | 1 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.01 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007420 | Biological process | brain development |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0048863 | Biological process | stem cell differentiation |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0001942 | Biological process | hair follicle development |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005575 | Cellular component | cellular_component |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | SOX21 |
| Protein name | Transcription factor SOX-21 (SOX-A) |
| Synonyms | SOX25 SOXA |
| Description | FUNCTION: May play a role as an activator of transcription of OPRM1. Overexpression of SOX21 can up-regulate the OPRM1 distal promoter activity in mor-expressing neuronal cells. May play a role in ameloblast differentiation. . |
| Accessions | Q9Y651 ENST00000376945.4 |